Previous 10 | Next 10 |
Bionano Genomics (BNGO) -22%.Stable Road Acquisition (SRAC) -12% Momentus updates on 2021 mission, merger with SRAC remains on track to close in Q1.ViewRay (VRAY) -12% after prices equity offering at $4.85.AirNet Technology (ANTE) -11%.TransEnterix (TRXC) -13%.Hall of...
ViewRay (VRAY) has priced its public offering of 10.31M common shares at $4.85/share, for gross proceeds of ~$50M.Underwriters' over-allotment is an additional ~1.55M shares. Net proceeds will be used for general corporate purposes, including working capital. Closing date is January 7.Shares&...
Gainers: [[AAME]] +53.3%. [[BPFH]] +27.8%. [[AIH]] +11.4%. [[ASLN]] +11.2%. [[GRTS]] +10.1%.Losers: [[VRAY]] -11.1%. [[GDS]] -8.4%. [[PBYI]] -5.5%. [[ACY]] -5.4%. [[GBIO]] -5.3%. For further details see: AAME, AIH, GDS and VRAY among after-hours movers
ViewRay (VRAY) commences an underwritten public offering of shares of its common stock. Underwriters option to purchase up to an additional 15% of the number of shares Actual size or terms not yet finalized.Net proceeds to be used for general corporate purposes, including working capital...
Gainers: Check-Cap (CHEK) +185%.Bionano Genomics (BNGO) +99%.The9 (NCTY) +92%.Ocugen (OCGN) +74%.Jaguar Health (JAGX) +42%.Pandion Therapeutics (PAND) +37%.ViewRay (VRAY) +33%.Bit Digital (BTBT) +29%.AirNet Technology (ANTE) +18%.Studio City International (MSC) +18%.Losers: ...
For Q4, ViewRay (VRAY) expects total revenue of ~$18M vs. $17M in the year ago quarter.The company received five new orders, including one upgrade, for MRIdian systems totaling ~$24M in Q4.FY20 revenue is seen at ~$57M vs. $88M in prior year.As of Dec.31, 2020, total backlog was ~$...
ViewRay Announces Preliminary Fourth Quarter and Full Year 2020 Results PR Newswire CLEVELAND, Ohio , Jan. 4, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 3...
ViewRay to Present at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire CLEVELAND , Dec. 23, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced its participation in the 39th Annual J.P. Morgan Healthcare Conference. Scott Drake , Pr...
Seoul National University Hospital Treats 1,000th Patient with MRIdian MRI-Guided Radiation Therapy Leading Healthcare Facility in South Korea Helps Advance the Practice of MRI-Guided Radiation Therapy Through Research, Protocols, and Publications PR Newswire CLEVE...
Eindhoven's Catharina Hospital Purchases ViewRay's MRIdian Linac Leading Clinical Training Hospital Aims to Begin MRIdian Patient Treatments in 2021 PR Newswire CLEVELAND , Dec. 21, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today t...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...